U.S. consumers remain optimistic about the potential of generative artificial intelligence to address healthcare access and affordability challenges, the new 2024 Deloitte Center for Health Solutions consumer survey shows. But they still have some misgivings about AI tools.
WHY IT MATTERS
Despite a general sense of optimism, the public’s use of genAI tools for health-related reasons has dipped a bit since the initial rush of interest that…